CYTOKINETICS, INCORPORATED Repayments of Bank Debt
CYTOKINETICS, INCORPORATED (CYTK) reported Repayments of Bank Debt of $12.44 million for the 194-month period ending 2013-09-30, per its 10-Q filed 2013-11-06.
Discontinued › Cash Flow › Financing Activities
us-gaap:RepaymentsOfBankDebt · last filed 2013-11-06
- CYTOKINETICS, INCORPORATED repayments of bank debt for the quarter ending 2010-12-31 was $0.00.
- CYTOKINETICS, INCORPORATED repayments of bank debt for the quarter ending 2010-09-30 was $0.00.
- CYTOKINETICS, INCORPORATED repayments of bank debt for fiscal 2010 was $10.20M, a 355.40% increase from fiscal 2009.
- CYTOKINETICS, INCORPORATED repayments of bank debt for fiscal 2009 was $2.24M.
| Period end | Repayments of Bank Debt 3 month | Repayments of Bank Debt 6 month | Repayments of Bank Debt 9 month | Repayments of Bank Debt 12 month | Repayments of Bank Debt 167 month | Repayments of Bank Debt 170 month | Repayments of Bank Debt 173 month | Repayments of Bank Debt 176 month | Repayments of Bank Debt 179 month | Repayments of Bank Debt 182 month | Repayments of Bank Debt 185 month | Repayments of Bank Debt 188 month | Repayments of Bank Debt 191 month | Repayments of Bank Debt 194 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2013-09-30 | $12.44M 10-Q · filed 2013-11-06 | |||||||||||||
| 2013-06-30 | $12.44M 10-Q · filed 2013-08-07 | |||||||||||||
| 2013-03-31 | $12.44M 10-Q · filed 2013-05-08 | |||||||||||||
| 2012-12-31 | $12.44M 10-K · filed 2013-03-15 | |||||||||||||
| 2012-09-30 | $12.44M 10-Q · filed 2012-11-07 | |||||||||||||
| 2012-06-30 | $12.44M 10-Q · filed 2012-08-06 | |||||||||||||
| 2012-03-31 | $12.44M 10-Q · filed 2012-05-04 | |||||||||||||
| 2011-12-31 | $12.44M 10-K · filed 2012-03-13 | |||||||||||||
| 2011-09-30 | $12.44M 10-Q · filed 2011-11-04 | |||||||||||||
| 2011-06-30 | $12.44M 10-Q · filed 2011-08-04 | |||||||||||||
| 2010-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-15 | $0.00 derived: sum of 2 quarters · filed 2013-03-15 | $10.20M 10-K · filed 2013-03-15 | |||||||||||
| 2010-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-04 | $10.20M 10-Q · filed 2011-11-04 | ||||||||||||
| 2010-06-30 | $10.20M 10-Q · filed 2011-08-04 | |||||||||||||
| 2009-12-31 | $2.24M 10-K · filed 2012-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 |